Finzati - Logo
MPLT logo

MapLight Therapeutics, Inc.

MPLT • Biotechnology
$13.77
▲ +0.63 (+4.79%)
Current price
EarningsLatest report: Mar 31, 2026
HIGHER-RISK PROFILECautionConfidence: 62%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$623.46M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.01Healthy liquidity · 20.01Weak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 14, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:34 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$13.77
Change4.79%
Shares Out45.28M
Market Cap$623.46M
Enterprise Value$314.27M
52W Range9.10 - 40.43
Beta2.65
P/E-3.13
P/B1.56
P/FCF-3.80
EV/EBITDA-1.51
EV/FCF-1.91

Investment DNA

How strong this company looks for long-term investors

47
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
89/100
Why this score▼
Manageable debt level · 0.01Healthy liquidity · 20.01Weak profitability

Analyst view

Analyst sentiment and price target

MPLT
Analyst sentiment
Based on 7 analyst votes · 2026-09-05
86/100
Bullish
Bullish
5
Hold
2
Bearish
0
Price Target
2026-08-14
Low
$13.00
Mean
$31.20
Median
$28.00
High
$46.00

Company Overview

IPO: 10/24/2025
Industry: Biotechnology
P/B i: 1.56
Debt / Equity i: 0.01
Operating Margin: 0.00%
Net Margin: 0.00%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.01
Current Ratio: 20.01
Quick Ratio: 20.01
Status: Good
🧾

No insider activity

No recent insider transactions available.